2022. Blood-Brain Barrier Penetration in Preclinical Screening: A Short Communication on Assay Discordance. Translational Medicine & Therapeutics Journal. 1, 1 (Jun. 2022), 56–64. DOI:https://doi.org/10.5281/zenodo.22648861.